Searched for
AMEERA 5
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Open to 4-5 acquisitions, but at sensible valuations: Ameera Shah, promoter and executive chairperson, Metropolis HealthcareMetropolis Healthcare is set for its next growth phase. The diagnostic chain will focus on genomics and specialty diagnostics. Strategic ac...
- Healthcare set to be more affordable as new GST rate kicks in from Sep 22: Pharma industryFrom September 22, medicines and medical devices in India will become cheaper under new GST rates, making healthcare more affordable, say i...
- Buy ACC, target price Rs 2,250: JM FinancialJM Financial has issued a buy call on ACC with a target price of Rs 2250, against the current market price of Rs 1832.95. ACC, a leading La...
- Hold Torrent Pharma, target price Rs 3,320: JM FinancialJM Financial recommends holding Torrent Pharmaceuticals with a target price of Rs 3,320, up from its current Rs 3,044.3. The company, a maj...
- Metropolis Q3 net profit rises 15.3% to Rs 31 crore, revenue up 11%Metropolis Healthcare on Tuesday reported a 15.3% year-on-year (YoY) rise in net profit to Rs 31 crore in Q3FY25 let my volume increase and...
- Metropolis Healthcare to acquire Core Diagnostics for Rs 247 crMetropolis will acquire a 100% stake in Core Diagnostics financing Rs 135.76 crores or 55% in cash and the rest Rs 111.07 through an equity...
- Metropolis Q1 results: Net profit rises 31% to Rs 38 croreThe earnings for interest, tax, depreciation and ammortisation (EBITDA) before CSR and ESOP rose 20.2% YoY to Rs 80.5 crore in Q1. The EBIT...
- Metropolis Healthcare Q4 Results: Net profit rises 8% to Rs 36 croreThe diagnostic chain reported Rs 33.5 crore net profit in the corresponding quarter of the previous year. Revenue from operations grew by 1...
- Buy Metropolis Healthcare, target price Rs 1420: Sharekhan by BNP ParibasMetropolis Healthcare, incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 6849.87 Crore) operating in Hospitals...
- Buy Torrent Pharmaceuticals, target price Rs 1788: Sharekhan by BNP ParibasThe sales growth beat over IPM is likely to be driven by new product launches, performance of its top brands, strong growth in its newly ac...
- Buy Metropolis Healthcare, target price Rs 1775: JM FinancialMetropolis Healthcare, incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 6731.32 Crore) operating in Hospitals...
- Buy Metropolis Healthcare, target price Rs 1978: BNP Paribas SecuritiesPromoters held 49.79 per cent stake in the company as of 30-Jun-2022, while FIIs owned 23.2 per cent, DIIs 14.5 per cent.
- Sanofi trial failure ends development of breast cancer treatment amcenestrantA trial dubbed AMEERA-5, which was testing amcenestrant on women with newly-diagnosed advanced breast cancer, was stopped early because an ...
- Healthcare service providers urge govt to increase healthcare spend in budget"The public spend in healthcare needs to increase from the current 1.2 per cent to at least 2.5 per cent of GDP in the next 3 years, much o...
- CLSA has maintains outperform on Torrent Pharma, raises target price to Rs 2,050The brokerage has raised earnings estimates by 1-3% after Q3 earnings beat estimates.
- Metropolis IPO gets oversubscribed 5.8xThe quota for qualified institutional buyers (QIBs) was over subscribed 8.8 times.
- Industry leaders hail national healthcare programmeThe move to cover 10 crore families with 5 lakh per family/per year for secondary and tertiary healthcare will be a game-changer, Apollo Ho...
- Metropolis Healthcare's Ameera Shah feels business mergers should be like relationshipsShah says mergers and acquisitions should be about forming bonds and not transactions.
- Burger fetches over Rs 4 lakh in UAETo spread awareness about the importance of early detection to fight breast cancer, Pink Caravan organised 'Pink Bite' charity auction to r...
Load More
